These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 107311)

  • 1. Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
    Kumar V; Remers WA
    J Med Chem; 1979 Apr; 22(4):432-6. PubMed ID: 107311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V; Jones GS; Blacksberg I; Remers WA; Misiek M; Pursiano TA
    J Med Chem; 1980 Jan; 23(1):42-9. PubMed ID: 6244410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 4. UK31214, a new aminoglycoside and derivative of kanamycin B.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):298-301. PubMed ID: 6775590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1-N-(2-aminoethanesulfonyl)-kanamycins and related aminoglycoside antibiotics.
    Akita E; Horiuchi Y; Miyazawa T; Umezawa H
    J Antibiot (Tokyo); 1983 Jun; 36(6):745-8. PubMed ID: 6409873
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside antibiotics. XI. Synthesis and activity of 4'-deoxykanamycin B.
    Abe Y; Nakagawa S; Fujisawa KI; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1977 Nov; 30(11):1004-7. PubMed ID: 412821
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminoglycoside antibiotics. IX. 1-N-acyl derivatives of kanamycin A (amikacin analogs).
    Naito T; Nakagawa S; Narita Y; Toda S; Abe Y
    J Antibiot (Tokyo); 1974 Nov; 27(11):851-8. PubMed ID: 4217789
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).
    Richardson K; Brammer KW; Jevons S; Plews RM; Wright JR
    J Antibiot (Tokyo); 1979 Oct; 32(10):973-7. PubMed ID: 528375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside antibiotics. VII. Synthesis and activity of 4'-deoxykanamycin A.
    Naito T; Nakagawa S; Abe Y; Fujisawa K; Kawaguchi H
    J Antibiot (Tokyo); 1974 Nov; 27(11):838-50. PubMed ID: 4217788
    [No Abstract]   [Full Text] [Related]  

  • 15. UK-18892, a new aminoglycoside: an in vitro study.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.